[Current methods for predicting therapeutic response in patients with depressive disorders].
Stanislav A GalkinSvetlana A IvanovaNikolay A BokhanPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)
Depressive disorder is the most common mental illness, which is also one of the leading causes of disability worldwide. In addition, most suicides are associated with depression. Despite all modern achievements in the treatment of depressive disorders, up to 60% of patients did not adequately respond to psychopharmacotherapy (non-responders). Current guidelines and studies characterize non-responders as patients who have an inadequate response to taking two or more antidepressants from different classes within 4 weeks. However, in some cases, such a long wait for a therapeutic response can lead to adverse consequences. Thus, there is a need to develop prognostic methods of therapeutic resistance in patients with depressive disorders. The purpose of this review is to summarize current methods used to predict therapeutic response in patients with depressive disorders. A literature search was conducted using the search terms «depression», «antidepressant», «outcome», «predictor», «(bio) marker», «treatment-resistant depression» and «chronic depression». The search was conducted in the PubMed, Scopus, and Google Scholar databases for the time period from 2005 to 2020.
Keyphrases
- bipolar disorder
- end stage renal disease
- depressive symptoms
- mental illness
- ejection fraction
- stress induced
- newly diagnosed
- major depressive disorder
- sleep quality
- mental health
- multiple sclerosis
- peritoneal dialysis
- emergency department
- physical activity
- patient reported
- drug induced
- smoking cessation
- case control